Overview

A Study of Acne Treatment in Children Ages 9 to 11

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
A study to determine if using Retin-A Micro 0.04% as facial acne treatment in patients ages 9 to 11 is safe and efficacious.
Phase:
Phase 2
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Treatments:
Benzoyl Peroxide
Tretinoin